Dexamethasone may affect the occurrence of parenteral nutrition-associated cholestasis in preterm neonates
IntroductionGlucocorticoids are currently used for the co-therapeutic management of autoimmune hepatitis and some cholestatic diseases. Thus far, we do not know the efficacy of glucocorticoids in the treatment of parenteral nutrition-associated cholestasis. We aimed to analyze whether the administra...
Saved in:
Main Authors: | Saizhi Jiang (Author), Qingqing Hu (Author), Jing Zhang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Risk Factors of Parenteral Nutrition-associated Cholestasis in Preterm Infants
by: Chien-Yi Chen, et al.
Published: (2009) -
Analysis of risk factors for parenteral nutrition-associated cholestasis in preterm infants: a multicenter observational study
by: Ya-sen Wang, et al.
Published: (2023) -
Correction: Analysis of risk factors for parenteral nutrition-associated cholestasis in preterm infants: a multicenter observational study
by: Ya-sen Wang, et al.
Published: (2023) -
Parenteral Nutrition-associated Cholestasis in Premature Babies: Risk Factors and Predictors
by: Meng-Han Hsieh, et al.
Published: (2009) -
Fish oil-based lipid emulsion in the treatment of parenteral nutrition-associated cholestasis
by: Simonetta Costa, et al.
Published: (2018)